Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'EXPERIMENTAL VISCERAL LEISHMANIASIS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 92 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Croft, SL
      Monitoring drug resistance in leishmaniasis

      TROPICAL MEDICINE & INTERNATIONAL HEALTH
    2. Rousseau, D; Demartino, S; Anjuere, F; Ferrua, B; Fragaki, K; Le Fichoux, Y; Kubar, J
      Sustained parasite burden in the spleen of Leishmania infantum-infected BALB/c mice is accompanied by expression of MCP-1 transcripts and lack of protection against challenge

      EUROPEAN CYTOKINE NETWORK
    3. Khaskhely, NM; Maruno, M; Takamiyagi, A; Uezato, H; Abul Kasem, KM; Hosokawa, A; Kariya, K; Hashiguchi, Y; Landires, EAG; Nonaka, S
      Pre-exposure with low-dose UVA suppresses lesion development and enhances Th1 response in BALB/c mice infected with Leishmania (Leishmania) amazonensis

      JOURNAL OF DERMATOLOGICAL SCIENCE
    4. Bhattacharyya, S; Ghosh, S; Sen, P; Roy, S; Majumdar, S
      Selective impairment of protein kinase C isotypes in murine macrophage by Leismania donovani

      MOLECULAR AND CELLULAR BIOCHEMISTRY
    5. Ghosh, A; Zhang, WW; Matlashewski, G
      Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections

      VACCINE
    6. Schopf, LR; Erickson, J; Hayes, L; Chung, C; Lavigne, L; Sypek, J
      Alterations of intralesional and lymph node gene expression and cellular composition induced by IL-12 administration during leishmaniasis

      PARASITE IMMUNOLOGY
    7. Perez-Santos, JLM; Talamas-Rohana, P
      In vitro indomethacin administration upregulates interleukin-12 productionand polarizes the immune response towards a Th1 type in susceptible BALB/cmice infected with Leishmania mexicana

      PARASITE IMMUNOLOGY
    8. Escobar, P; Yardley, V; Croft, SL
      Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    9. Bourreau, E; Prevot, G; Gardon, J; Pradinaud, R; Launois, P
      High intralesional interleukin-10 messenger RNA expression in localized cutaneous Leishmaniasis is associated with unresponsiveness to treatment

      JOURNAL OF INFECTIOUS DISEASES
    10. Cordeiro-Da-Silva, A; Borges, MC; Guilvard, E; Ouaissi, A
      Dual role of the Leishmania major ribosomal protein S3a homologue in regulation of T- and B-cell activation

      INFECTION AND IMMUNITY
    11. Melby, PC; Tabares, A; Restrepo, BI; Cardona, AE; McGuff, HS; Teale, JM
      Leishmania donovani: Evolution and architecture of the splenic cellular immune response related to control of infection

      EXPERIMENTAL PARASITOLOGY
    12. Alexander, CE; Kaye, PM; Engwerda, CR
      CD95 is required for the early control of parasite burden in the liver of Leishmania donovani-infected mice

      EUROPEAN JOURNAL OF IMMUNOLOGY
    13. Murphy, ML; Wille, U; Villegas, EN; Hunter, CA; Farrell, JP
      IL-10 mediates susceptibility to Leishmania donovani infection

      EUROPEAN JOURNAL OF IMMUNOLOGY
    14. Lang, T; Ave, P; Huerre, M; Milon, G; Antoine, JC
      Macrophage subsets harbouring Leishmania donovani in spleens of infected BALB/c mice: localization and characterization

      CELLULAR MICROBIOLOGY
    15. Xing, Z; Wang, J
      Consideration of cytokines as therapeutics agents or targets

      CURRENT PHARMACEUTICAL DESIGN
    16. Scott, CL; Roe, L; Curtis, J; Baldwin, T; Robb, L; Begley, CG; Handman, E
      Mice unresponsive to GM-CSF are unexpectedly resistant to cutaneous Leishmania major infection

      MICROBES AND INFECTION
    17. Lehmann, J; Enssle, KH; Lehmann, I; Emmendorfer, A; Lohmann-Matthes, ML
      The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    18. Hamerlinck, FFV; van Gool, T; Faber, WR; Kager, PA
      Serum neopterin concentrations during treatment of leishmaniasis: useful as test of cure?

      FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
    19. Eslami, Z; Tanner, CE
      rIL-2-stimulated splenocytes reactivate the NO2-producing ability of macrophages infected by Leishmania donovani

      IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
    20. da Silva, VO; Borja-Cabrera, GP; Pontes, NNC; de Souza, EP; Luz, KG; Palatnik, M; de Sousa, CBP
      A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amaranto, RN)

      VACCINE
    21. Dole, VS; Raj, VS; Ghosh, A; Madhubala, R; Myler, PJ; Stuart, KD
      Immunization with recombinant LD1 antigens protects against experimental leishmaniasis

      VACCINE
    22. Engwerda, CR; Kaye, PM
      Organ-specific immune responses associated with infectious disease

      IMMUNOLOGY TODAY
    23. Requena, JM; Soto, M; Doria, MD; Alonso, C
      Immune and clinical parameters associated with Leishmania infantum infection in the golden hamster model

      VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
    24. Moreno, J; Canavate, C; Chamizo, C; Laguna, F; Alvar, J
      HIV-Leishmania infantum co-infection: humoral and cellular immune responses to the parasite after chemotherapy

      TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
    25. Smelt, SC; Cotterell, SEJ; Engwerda, CR; Kaye, PM
      B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology

      JOURNAL OF IMMUNOLOGY
    26. Gomes, NA; Gattass, CR; Barreto-de-Souza, V; Wilson, ME; DosReis, GA
      TGF-beta mediates CTLA-4 suppression of cellular immunity in murine kalaazar

      JOURNAL OF IMMUNOLOGY
    27. Pinto, AR; Beyrodt, CGP; Antonio, R; Lopes, M; Barbieri, CL
      Identification of a 30 kDa antigen from Leishmania (L.) chagasi amastigotes implicated in protective cellular responses in a murine model

      INTERNATIONAL JOURNAL FOR PARASITOLOGY
    28. Coterell, SEJ; Engwerda, CR; Kaye, PM
      Enhanced hematopoietic activity accompanies parasite expansion in the spleen and bone marrow of mice infected with Leishmania donovani

      INFECTION AND IMMUNITY
    29. Streit, JA; Recker, TJ; Donelson, JE; Wilson, ME
      BCG expressing LCR1 of Leishmania chagasi induces protective immunity in susceptible mice

      EXPERIMENTAL PARASITOLOGY
    30. Satoskar, AR; Rodig, S; Telford, SR; Satoskar, AA; Ghosh, SK; von Lichtenberg, F; David, JR
      IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology

      EUROPEAN JOURNAL OF IMMUNOLOGY
    31. Cotterell, SEJ; Engwerda, CR; Kaye, PM
      Leishmania donovani infection of bone marrow stromal macrophages selectively enhances myelopoiesis, by a mechanism involving GM-CSF and TNF-alpha

      BLOOD
    32. Murray, HW
      Kala-azar as an AIDS-related opportunistic infection

      AIDS PATIENT CARE AND STDS
    33. Saha, A; Chakrabarti, G; Sen, S; Bandyopadhyay, S
      Leishmania donovani parasites interact with gamma/delta(+) human peripheral blood T cells and induce susceptibility to NK cell-mediated lysis

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    34. Das, G; Vohra, H; Rao, K; Saha, B; Mishra, GC
      Leishmania donovani infection of a susceptible host results in CD4(+) T-cell apoptosis and decreased Th1 cytokine production

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    35. Ghose, AC; Mookerjee, A; Sengupta, K; Ghosh, AK; Dasgupta, S; Ray, PK
      Therapeutic and prophylactic uses of Protein A in the control of Leishmania donovani infection in experimental animals

      IMMUNOLOGY LETTERS
    36. Petit, C; Yardley, V; Gaboriau, F; Bolard, J; Croft, SL
      Activity of a heat-induced reformulation of amphotericin B deoxycholate (Fungizone) against Leishmania donovani

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    37. Sato, N; Kuziel, WA; Melby, PC; Reddick, RL; Kostecki, V; Zhao, WG; Maeda, N; Ahuja, SK; Ahuja, SS
      Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice

      JOURNAL OF IMMUNOLOGY
    38. Alexander, J; Satoskar, AR; Russell, DG
      Leishmania species: models of intracellular parasitism

      JOURNAL OF CELL SCIENCE
    39. Saha, B; Saini, A; Germond, R; Perrin, PJ; Harlan, DM; Davis, TA
      Susceptibility or resistance to Leishmania infection is dictated by the macrophages evolved under the influence of IL-3 or GM-CSF

      EUROPEAN JOURNAL OF IMMUNOLOGY
    40. Cotterell, SEJ; Engwerda, CR; Kaye, PM
      Leishmania donovani infection initiates T cell-independent chemokine responses, which are subsequently amplified in a T cell-dependent manner

      EUROPEAN JOURNAL OF IMMUNOLOGY
    41. Das, G; Vohra, H; Saha, B; Agrewala, JN; Mishra, GC
      Leishmania donovani infection of a susceptible host results in apoptosis of Th1-like cells: Rescue of anti-leishmanial CMI by providing Th1-specific bystander costimulation

      MICROBIOLOGY AND IMMUNOLOGY
    42. BALANAFOUCE R; REGUERA RM; CUBRIA JC; ORDONEZ D
      THE PHARMACOLOGY OF LEISHMANIASIS

      General pharmacology
    43. LEHMANN J; ALBER G
      MURINE LEISHMANIASIS - A PARADIGM FOR THE IMPORTANCE OF T-HELPER-1 AND T-HELPER-2 CELLS

      Revue scientifique et technique - Office international des epizooties
    44. OSTERRIEDER N; WOLF E
      LESSONS FROM GENE KNOCKOUTS

      Revue scientifique et technique - Office international des epizooties
    45. LUTSIAK CME; SOSNOWSKI DL; WISHART DS; KWON GS; SAMUEL J
      USE OF A LIPOSOME ANTIGEN DELIVERY SYSTEM TO ALTER IMMUNE-RESPONSES IN-VIVO

      Journal of pharmaceutical sciences
    46. AFRIN F; ALI N
      ISOTYPE PROFILES OF LEISHMANIA-DONOVANI-INFECTED BALB C MICE - PREFERENTIAL STIMULATION OF IGG2A/B BY LIPOSOME-ASSOCIATED PROMASTIGOTE ANTIGENS/

      The Journal of parasitology
    47. MUKHOPADHYAY S; SEN P; MAJUMDER HK; ROY S
      REDUCED EXPRESSION OF LIPOPHOSPHOGLYCAN (LPG) AND KINETOPLASTID MEMBRANE-PROTEIN (KMP)-11 IN LEISHMANIA-DONOVANI PROMASTIGOTES IN AXENIC CULTURE

      The Journal of parasitology
    48. MURPHY ML; COTTERELL SEJ; GORAK PMA; ENGWERDA CR; KAYE PM
      BLOCKADE OF CTLA-4 ENHANCES HOST-RESISTANCE TO THE INTRACELLULAR PATHOGEN, LEISHMANIA-DONOVANI

      The Journal of immunology (1950)
    49. BOGDAN C; ROLLINGHOFF M
      THE IMMUNE-RESPONSE TO LEISHMANIA - MECHANISMS OF PARASITE CONTROL AND EVASION

      International journal for parasitology
    50. TRAVI BL; OSORIO Y; GUARIN N; CADENA H
      LEISHMANIA (LEISHMANIA) CHAGASI - CLINICAL AND PARASITOLOGICAL OBSERVATIONS IN EXPERIMENTALLY INFECTED DIDELPHIS-MARSUPIALIS, RESERVOIR OF NEW-WORLD VISCERAL LEISHMANIASIS

      Experimental parasitology
    51. ENGWERDA CR; MURPHY ML; COTTERELL SEJ; SMELT SC; KAYE PM
      NEUTRALIZATION OF IL-12 DEMONSTRATES THE EXISTENCE OF DISCRETE ORGAN-SPECIFIC PHASES IN THE CONTROL OF LEISHMANIA-DONOVANI

      European Journal of Immunology
    52. Saha, B; Chattopadhyay, S; Germond, R; Harlan, DM; Perrin, PJ
      CTLA4 (CD152) modulates the Th subset response and alters the course of experimental Leishmania major infection

      EUROPEAN JOURNAL OF IMMUNOLOGY
    53. WU AY; SCHULMAN SJ; MARCONI LA; REILLY CR; SCOTT B; LO DV
      PROTECTION AGAINST DIABETES BY MHC HETEROZYGOSITY AND REVERSAL BY CYCLOPHOSPHAMIDE

      Cellular immunology
    54. CHAKRABORTY P; BASU MK
      LEISHMANIA PHAGOLYSOSOME - DRUG TRAFFICKING AND PROTEIN SORTING ACROSS THE COMPARTMENT

      Critical reviews in microbiology
    55. VANGOMPEL A; VERVOORT T
      CHEMOTHERAPY OF LEISHMANIASIS AND TRYPANOSOMIASIS

      Current opinion in infectious diseases
    56. PEPIN M; SEOW HF; CORNER L; ROTHEL JS; HODGSON ALM; WOOD PR
      CYTOKINE GENE-EXPRESSION IN SHEEP FOLLOWING EXPERIMENTAL-INFECTION WITH VARIOUS STRAINS OF CORYNEBACTERIUM-PSEUDOTUBERCULOSIS DIFFERING IN VIRULENCE

      Veterinary research
    57. ALVAR J; CANAVATE C; GUTIERREZSOLAR B; JIMENEZ M; LAGUNA F; LOPEZVELEZ R; MOLINA R; MORENO J
      LEISHMANIA AND HUMAN-IMMUNODEFICIENCY-VIRUS COINFECTION - THE FIRST 10 YEARS

      Clinical microbiology reviews
    58. ALVAR J; CANAVATE C; GUTIERREZSOLAR B; JIMENEZ M; LAGUNA F; LOPEZVELEZ R; MOLINA R; MORENO J
      LEISHMANIA AND HUMAN-IMMUNODEFICIENCY-VIRUS COINFECTION - THE FIRST 10 YEARS

      Clinical microbiology reviews
    59. MURPHY ML; ENGWERDA CR; GORAK PMA; KAYE PM
      B7-2 BLOCKADE ENHANCES T-CELL RESPONSES TO LEISHMANIA-DONOVANI

      The Journal of immunology
    60. SARKAR K; DAS PK
      PROTECTIVE EFFECT OF NEOGLYCOPROTEIN-CONJUGATED MURAMYL DIPEPTIDE AGAINST LEISHMANIA-DONOVANI INFECTION - THE ROLE OF CYTOKINES

      The Journal of immunology
    61. KONG DQ; BELOSEVIC M; KUNIMOTO DY
      IMMUNIZATION OF BALB C MICE WITH MIFN-GAMMA-SECRETING MYCOBACTERIRM BOVIS BCG PROVIDES EARLY PROTECTION AGAINST LEISHMANIA-MAJOR INFECTION/

      International journal for parasitology
    62. AFRIN F; ALI N
      ADJUVANTICITY AND PROTECTIVE IMMUNITY ELICITED BY LEISHMANIA-DONOVANIANTIGENS ENCAPSULATED IN POSITIVELY CHARGED LIPOSOMES

      Infection and immunity
    63. PARKAS V; GODWIN J; MURRAY HW
      KALA-AZAR COMES TO NEW-YORK

      Archives of internal medicine
    64. MEHLOTRA RK
      ANTIOXIDANT DEFENSE-MECHANISMS IN PARASITIC PROTOZOA

      Critical reviews in microbiology
    65. LEITE VHR; CROFT SL
      HEPATIC EXTRACELLULAR-MATRIX IN BALB C MICE INFECTED WITH LEISHMANIA-DONOVANI/

      International journal of experimental pathology
    66. SARKAR K; SARKAR HS; KOLE L; DAS PK
      RECEPTOR-MEDIATED ENDOCYTOSIS OF FUCOSYLATED NEOGLYCOPROTEIN BY MACROPHAGES

      Molecular and cellular biochemistry
    67. PALATNIKDESOUSA CB; PARAGUAIDESOUZA E; GOMES EM; SOARESMACHADO FC; BOROJEVIC R
      TRANSMISSION OF VISCERAL LEISHMANIASIS BY BLOOD-TRANSFUSION IN HAMSTERS

      Brazilian journal of medical and biological research
    68. OLIVIER M; ESLAMI Z; TANNER CE
      IL-2-STIMULATED SPLENOCYTES REDUCE INFECTIONS BY LEISHMANIA-DONOVANI IN-VIVO

      The Journal of parasitology
    69. WILSON ME; SANDOR M; BLUM AM; YOUNG BM; METWALI A; ELLIOTT D; LYNCH RG; WEINSTOCK JV
      LOCAL SUPPRESSION OF IFN-GAMMA IN HEPATIC GRANULOMAS CORRELATES WITH TISSUE-SPECIFIC REPLICATION OF LEISHMANIA-CHAGASI

      The Journal of immunology
    70. ENGWERDA CR; SMELT SC; KAYE PM
      AN IN-VIVO ANALYSIS OF CYTOKINE PRODUCTION DURING LEISHMANIA-DONOVANIINFECTION IN SCID MICE

      Experimental parasitology
    71. BADOLATO R; SACKS DL; SAVOIA D; MUSSO T
      LEISHMANIA-MAJOR - INFECTION OF HUMAN MONOCYTES INDUCES EXPRESSION OFIL-8 AND MCAF

      Experimental parasitology
    72. BARRALNETTO M; VONSOHSTEN RL; TEIXEIRA M; DOSSANTOS WLC; POMPEU ML; MOREIRA RA; OLIVEIRA JTA; CAVADA BS; FALCOFF E; BARRAL A
      IN-VIVO PROTECTIVE EFFECT OF THE LECTIN FROM CANAVALIA-BRASILIENSIS ON BALB C MICE INFECTED BY LEISHMANIA-AMAZONENSIS/

      Acta Tropica
    73. ASANO M; NAKANE A; KOHANAWA M; MINAGAWA T
      SEQUENTIAL INVOLVEMENT OF NK CELLS AND CD8(-CELLS IN GRANULOMA-FORMATION OF RHODOCOCCUS AURANTIACUS-INFECTED MICE() T)

      Microbiology and immunology
    74. ESLAMI Z; OLIVIER M; TANNER CE
      IMMUNOTHERAPY WITH IL-2-STIMULATED SPLENOCYTES REDUCES IN-VITRO THE LEVEL OF LEISHMANIA-DONOVANI INFECTION IN PERITONEAL-MACROPHAGES

      International journal for parasitology
    75. WILSON ME; YOUNG BM; ANDERSEN KP; WEINSTOCK JV; METWALI A; ALI KM; DONELSON JE
      A RECOMBINANT LEISHMANIA-CHAGASI ANTIGEN THAT STIMULATES CELLULAR IMMUNE-RESPONSES IN INFECTED MICE

      Infection and immunity
    76. ZEHRA K; PAL R; ANURADHA; RIZVI SY; HAQ W; KUNDU B; KATIYAR JC; MATHUR KB
      LEISHMANIA-DONOVANI IN HAMSTERS - STIMULATION OF NONSPECIFIC RESISTANCE BY NOVEL LIPOPEPTIDES AND THEIR EFFECT IN ANTILEISHMANIAL THERAPY

      Experientia
    77. HOMMEL M; JAFFE CL; TRAVI B; MILON G
      EXPERIMENTAL-MODELS FOR LEISHMANIASIS AND FOR TESTING ANTILEISHMANIALVACCINES

      Annals of tropical medicine and parasitology
    78. NABORS GS; FARRELL JP
      ACTIVITY OF PENTOSTAM (SODIUM-STIBOGLUCONATE) AGAINST CUTANEOUS LEISHMANIASIS IN MICE TREATED WITH NEUTRALIZING ANTI-INTERFERON-GAMMA ANTIBODY

      The American journal of tropical medicine and hygiene
    79. KAYE PM
      LEISHMANIASIS - IMMUNOLOGY, PERSISTENCE AND ANTIGEN PRESENTATION

      Bailliere's clinical infectious diseases
    80. MURRAY HW
      CYTOKINES IN THE TREATMENT OF LEISHMANIASIS

      Bailliere's clinical infectious diseases
    81. MULLER I; KROPF P; LOUIS JA; MILON G
      EXPANSION OF GAMMA-INTERFERON-PRODUCING CD8-CELLS FOLLOWING SECONDARYINFECTION OF MICE IMMUNE TO LEISHMANIA-MAJOR( T)

      Infection and immunity
    82. KOLE L; SARKAR K; MAHATO SB; DAS PK
      NEOGLYCOPROTEIN CONJUGATED LIPOSOMES AS MACROPHAGE SPECIFIC DRUG CARRIER IN THE THERAPY OF LEISHMANIASIS

      Biochemical and biophysical research communications
    83. DEGLING L; STJARNKVIST P; SJOHOLM I
      BIODEGRADABLE MICROSPHERES .15. INTERFERON-GAMMA IN STARCH MICROPARTICLES - NITRIC OXIDE-GENERATING ACTIVITY INVITRO AND ANTILEISHMANIAL EFFECT IN MICE

      Pharmaceutical research
    84. TRAVI BL; MARTINEZ JE; ZEA A
      ANTIMONIAL TREATMENT OF HAMSTERS INFECTED WITH LEISHMANIA (VIANNIA) PANAMENSIS - ASSESSMENT OF PARASITOLOGICAL CURE WITH DIFFERENT THERAPEUTIC SCHEDULES

      Transactions of the Royal Society of Tropical Medicine and Hygiene
    85. MURRAY HW; TEITELBAUM R; HARIPRASHAD J
      RESPONSE TO TREATMENT FOR AN INTRACELLULAR INFECTION IN A T-CELL-DEFICIENT HOST - TOXOPLASMOSIS IN NUDE-MICE

      The Journal of infectious diseases
    86. MULLER I; KROPF P; ETGES RJ; LOUIS JA
      GAMMA-INTERFERON RESPONSE IN SECONDARY LEISHMANIA-MAJOR INFECTION - ROLE OF CD8-CELLS( T)

      Infection and immunity
    87. MCMAHONPRATT D; RODRIGUEZ D; RODRIGUEZ JR; YA Z; MANSON K; BERGMAN C; RIVAS L; RODRIGUEZ JF; LOHMAN KL; RUDDLE NH; ESTEBAN M
      RECOMBINANT VACCINIA VIRUSES EXPRESSING GP46 M-2 PROTECT AGAINST LEISHMANIA INFECTION

      Infection and immunity
    88. MANNA PP; BHARADWAJ D; BHATTACHARYA S; CHAKRABARTI G; BASU D; MALLIK KK; BANDYOPADHYAY S
      IMPAIRMENT OF NATURAL-KILLER-CELL ACTIVITY IN INDIAN KALA-AZAR - RESTORATION OF ACTIVITY BY INTERLEUKIN-2 BUT NOT BY ALPHA-INTERFERON OR GAMMA-INTERFERON

      Infection and immunity
    89. ASANO M; NAKANE A; MINAGAWA T
      ENDOGENOUS GAMMA-INTERFERON IS ESSENTIAL IN GRANULOMA-FORMATION INDUCED BY GLYCOLIPID-CONTAINING MYCOLIC ACID IN MICE

      Infection and immunity
    90. KAUSALYA S; MALLA N; GANGULY NK; MAHAJAN RC
      LEISHMANIA-DONOVANI - IN-VITRO EVIDENCE OF HEPATOCYTE DAMAGE BY KUPFFER CELLS AND IMMIGRANT MACROPHAGES IN A MURINE MODEL

      Experimental parasitology
    91. CHAN MMY
      T-CELL RESPONSE IN MURINE LEISHMANIA-MEXICANA-AMAZONENSIS INFECTION -PRODUCTION OF INTERFERON-GAMMA BY CD8+ CELLS

      European Journal of Immunology
    92. MULLER I; FRUTH U; LOUIS JA
      IMMUNOBIOLOGY OF EXPERIMENTAL LEISHMANIASIS

      Medical microbiology and immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/01/21 alle ore 02:52:13